12943_2019_1080_MOESM9_ESM.pdf (531.15 kB)
MOESM9 of CircPLEKHM3 acts as a tumor suppressor through regulation of the miR-9/BRCA1/DNAJB6/KLF4/AKT1 axis in ovarian cancer
journal contribution
posted on 2019-10-18, 09:27 authored by Lei Zhang, Qing Zhou, Qiongzi Qiu, Ling Hou, Mengting Wu, Jia Li, Xufan Li, Bingjian Lu, Xiaodong Cheng, Pengyuan Liu, Weiguo Lu, Yan LuAdditional file 9: Figure S6. PLEKHM3 expression is not associated with survivals of ovarian cancer patients. (A) The protein expression of PLEKHM3 was measured by IHC analysis. Nine of eighty-six patients either failed to have a good IHC staining or did not acquired additional FFPE tissue blocks. (B) KaplanâMeier survival analysis of PLEKHM3 expression in ovarian cancer patients. Differences in the survival risk between the two groups were assessed by the MantelâHaenszel log-rank test.
